Evidence map›Paper›PMID 33610946›Full record

ArticleJournal of psychiatric research2021

Top problems of adolescents and young adults with ADHD during the COVID-19 pandemic.

Margaret H Sibley, Mercedes Ortiz, Larissa M Gaias, Rosemary Reyes, Mahima Joshi, Dana Alexander, Paulo Graziano

Open access · greenAbstract read
In one paragraph

Article in Journal of psychiatric research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed, 1 pooled it
14.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 1 synthesis or guideline pooled it, 114 citations in OpenAlex.

  1. The COVID-19 pandemic and adolescents' and young adults' experiences at school: A systematic narrative review.Journal of research on adolescence : the official journal of the Society for Research on Adolescence · 2025
    Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Drug Shortages for Prescription Amphetamine Derivatives.The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG · 2025
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Trends in Mental Wellbeing of US Children, 2019-2022: Erosion of Mental Health Continued in 2022.International journal of environmental research and public health · 2024
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Margaret H SibleyUniversity of Washington, 1410 Campus Parkway, Seattle, WA, USA; Seattle Children's Research Institute, 1900 9th Avenue, Seattle, WA, USA. Electronic address: margaret.sibley@seattlechildrens.org.
Mercedes OrtizSeattle Children's Research Institute, 1900 9th Avenue, Seattle, WA, USA.
Larissa M GaiasUniversity of Massachusetts Lowell, 220 Pawtucket St, Lowell, MA, USA.
Rosemary ReyesUniversity of Washington, 1410 Campus Parkway, Seattle, WA, USA.
Mahima JoshiUniversity of Washington, 1410 Campus Parkway, Seattle, WA, USA.
Dana AlexanderUniversity of Washington, 1410 Campus Parkway, Seattle, WA, USA.
Paulo GrazianoFlorida International University, 11200 SW 8th Street, Miami, FL, USA.
University of Washington · USCenter for Infectious Disease Research · USFlorida International University · USUniversity of Massachusetts Lowell · US

Funding

Effectiveness of MI Enhanced Behavior Therapy for Adolescents with ADHDR01MH106587 · NIMH · SEATTLE CHILDREN'S HOSPITAL · PI SIBLEY, MARGARET HARPER · 2015 to 2018
$1.7M
NIMH NIH HHS R01 MH106587
6 · The paper itself

Abstract

objectiveADHD symptom severity appears to be exacerbated during the COVID-19 pandemic. The present study surveyed top problems experienced by adolescents and young adults (A/YAs) with ADHD during the COVID-19 pandemic to identify possible reasons for symptom escalation and potential targets for intervention. We also explored perceived benefits of the pandemic for A/YAs with ADHD.

methodAt the outbreak of the COVID-19 pandemic (April-June 2020), we administered self and parent ratings about current and pre-pandemic top problem severity and benefits of the pandemic to a sample of convenience (N = 134 A/YAs with ADHD participating in a prospective longitudinal study).

resultsThe most common top problems reported in the sample were social isolation (parent-report: 26.7%; self-report: 41.5%), difficulties engaging in online learning (parent-report: 23.3%, self-report: 20.3%), motivation problems (parent-report: 27.9%), and boredom (self-report: 21.3%). According to parent (d = 0.98) and self-report (d = 1.33), these top problems were more severe during the pandemic than in prior months. Contrary to previous speculation, there was no evidence that pandemic-related changes mitigated ADHD severity. Multi-level models indicated that A/YAs with higher IQs experienced severer top problems exacerbations at the transition to the COVID-19 pandemic.

conclusionsFor A/YAs with ADHD, several risk factors for depression and school dropout were incurred during the early months of the COVID-19 pandemic. A/YAs with ADHD should be monitored for school disengagement and depressive symptoms during the COVID-19 pandemic. Recommended interventions attend to reducing risk factors such as increasing social interaction, academic motivation, and behavioral activation among A/YAs with ADHD.

Indexed as

BoredomMotivationPandemicsAdolescentAttention Deficit Disorder with HyperactivityCOVID-19DepressionFemaleHumansLongitudinal StudiesMaleProspective StudiesSelf ReportYoung AdultADHDAdolescenceCOVID-19

Identifiers

PMID33610946
PMCPMC8009847
OpenAlexW3133071574

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.